This is one of my favorite interviews as it tells the story of the phase 1 trials of ibrutinib and idelalisib (CAL 101) by Dr. Furman who was the investigator for them both. See bkoffman.blogspot.com
ASH 2012 Interview with Dr. Rick Furman - CLL Support
ASH 2012 Interview with Dr. Rick Furman
Written by
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Read more about...
3 Replies
•
Hi Brian,
Thanks for that.
Liked the Leonard Cohen at the IOW I saw him at the O2 centre in London a few years ago. He still has 'it' and it was a great show. Many other musicians there, including David Gilmour from Pink Floyd.
Hi Its interesting to hear how important it is to listen to patients and their views when trying new drugs.
bkoffmanCLL CURE Hero
@jangreen. Agreed. We all learn from each other.
Not what you're looking for?
You may also like...
ASH 2017: Dr. Richard Furman on the importance of MCL-1 in CLL (chronic lymphocytic leukemia)
used in combination with ibrutinib or rituximab. See this on the Murano trial from ASH 2017 that...
Dr. Furman on the Diminishing Role of FCR
text from Dr. Furman's post https://cllsociety.org/2017/12/one-mans-opinion-fcr-vs-ibrutinib/....
ASH 2012 Ibrutinib Press Conference
Patient Power Video...
ASH 2018: Dr. Kipps on antibodies and Venetoclax resistance
always continue to work. In the first part of my interview with Dr. Kipps at ASH 2018, he discusses...
My 1 year CAR-T anniversary and from ASH 2018, Dr. Siddiqi on how CLL treatment has changed.
https://cllsociety.org/2019/03/one-year-anniversary/
Also this week, I posted a brief ASH 2018...